Pharma and MMJ – United Patients Group

Breast Cancer, Cannabis, and Tamoxifen: Understanding the Dangers of Drug-Drug Interactions

For many people living with life-limiting and life-threatening diseases like…

August 31, 2017Breast Cancer, Cancer, Headlines, Pharma and MMJ, Popular, United Patients GroupBy Beth

Cannabis Topicals: Creams, Salves and Lotions. Why Seniors are Thriving.

When we think of pain relief from cannabis, we often…

April 20, 2017Endocannabinoid System, Headlines, Health, Inflammation, Medical Marijuana, Neuropathic Pain, Pain Relief, Pharma and MMJ, Popular, Skin Cancer, Skin Conditions, Transdermal Cannabinoid Delivery, United Patients GroupBy Beth

The Raw Truth About Cannabis and Spinal Cord Injuries

Did you know as many as 450,000 people in the United States alone are living with a spinal cord injury?

March 20, 2017Headlines, Pain Relief, Pharma and MMJ, PopularBy Beth

How Cannabis Interacts with Pharmaceuticals: What You Need To Know

In the recent November elections, we reached a crucial turning point in cannabis decriminalization: over half the states now have cannabis legalized in some form or another.

February 17, 2017Headlines, Pharma and MMJ, Popular, SeniorsBy UPG Staff

Addiction Treatment: Can Cannabis Replace Synthetic Opioids in Treating Addiction?

Despite harsh laws enforced by the “War on Drugs,” drug abuse is still a major issue in the United States. Even more worrying is the number of accidental deaths caused by drug overdoses every year. In fact, in 2014, there were 47,055 accidental deaths from drug overdoses in the US, making it the highest cause of accidental death in the country.

January 14, 2017Headlines, Pain Relief, Pharma and MMJ, PopularBy UPG Staff

FDA Fast Tracks Approval of Controversial Drug for Muscular Dystrophy – Why is Cannabis Not Being Given the Same Consideration?

An emotionally-charged panel hearing on September 19th ended with the FDA approving a controversial Muscular Dystrophy drug called eteplirsen, also known as exondys 51. In an effort to keep patients in the approval process, the event was marked by speeches from patients and family members of patients urging the FDA to approve the drug.

September 23, 2016Pharma and MMJ, PopularBy UPG Staff